|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
University of Auckland, New Zealand |
| Information provided by: | University of Auckland, New Zealand |
| ClinicalTrials.gov Identifier: | NCT00642005 |
Purpose
Laparoscopic surgery allows surgeons to remove bowel via small incisions. To allow insertion of a camera and instruments, cold and dry gas is blown into the abdominal cavity. This project investigates the use of warmed, humidified gas in laparoscopic surgery. The hypothesis is that this will result in less damage to internal surfaces, and shorten recovery time. Previous studies have demonstrated positive outcomes in laparoscopic gallbladder operations. We plan to study patients undergoing laparoscopic colon operations, as these operations are longer and the effect of humidification will be magnified. We will enroll 70 patients: 35 will have the operation with cold dry gas, and 35 will have warm, humidified gas. We will measure intraoperative heat loss, postoperative pain, fatigue, nausea and vomiting, and time to return of bowel function.
| Condition | Intervention |
|
Peritoneal Inflammation |
Procedure: Fisher and Paykel Humidifier Procedure: Standard insufflation |
| MedlinePlus related topics: | Nausea and Vomiting |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Placebo Control, Single Group Assignment, Efficacy Study |
| Official Title: | Humidification in Laparoscopic Colonic Surgery - A Double Blinded, Randomised Controlled Trial. |
| Estimated Enrollment: | 70 |
| Study Start Date: | April 2008 |
| Estimated Study Completion Date: | December 2009 |
| Estimated Primary Completion Date: | October 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|
1: Experimental
Humidified and warmed carbon dioxide laparoscopic insufflation.
|
Procedure: Fisher and Paykel Humidifier
Humidification to 98% relative humidity, and warming to 40 degrees C of laparoscopic insufflate. This will be done for the duration of the operation.
|
|
2: Placebo Comparator
Cold and dry carbon dioxide laparoscopic insufflation.
|
Procedure: Standard insufflation
No humidifer or warmer will be used (device switched off). This will deliver laparoscopic insufflate at 0% humidity and 20 degrees C.
|
![]() |
Show Detailed Description |
Eligibility
| Ages Eligible for Study: | 15 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Tarik Sammour, MBChB | +6421317417 | tsammour@middlemore.co.nz |
| New Zealand | |||||
| Auckland City Hospital | Recruiting | ||||
| Auckland, New Zealand | |||||
| Contact: Tarik Sammour, MBChB +6421317417 tsammour@middlemore.co.nz | |||||
| Principal Investigator: Tarik Sammour, MBChB | |||||
| Sub-Investigator: Julian Hayes, MBChB, FRACS | |||||
| North Shore Hospital | Recruiting | ||||
| Auckland, New Zealand | |||||
| Contact: Tarik Sammour, MBChB +6421317417 tsammour@middlemore.co.nz | |||||
| Principal Investigator: Tarik Sammour, MBChB | |||||
| Sub-Investigator: Mike Hulme-Moir, MBChB, FRACS | |||||
| New Zealand, Otahuhu | |||||
| Middlemore Hospital | Recruiting | ||||
| Auckland, Otahuhu, New Zealand | |||||
| Contact: Tarik Sammour, MBChB +6421317417 tsammour@middlemore.co.nz | |||||
| Principal Investigator: Tarik Sammour, MBChB | |||||
| Sub-Investigator: Andrew Hill, MBChB, MD, FRACS | |||||
| University of Auckland, New Zealand |
| Study Chair: | Andrew G Hill, MBChB, MD, FRACS | University of Auckland, New Zealand |
More Information
| Responsible Party: | Department of Surgery, South Auckland Clinical School, University of Auckland ( Dr Tarik Sammour ) |
| Study ID Numbers: | Laphumid |
| First Received: | March 17, 2008 |
| Last Updated: | April 14, 2008 |
| ClinicalTrials.gov Identifier: | NCT00642005 |
| Health Authority: | New Zealand: Health and Disability Ethics Committees |
|
|
|